REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Prophar S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Retail Trade | Lessors of Real Estate | Administrative Management and General Management Consulting Services
Full name: Prophar S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Prophar S.A. is an enterprise located in Ecuador, with the main office in Sangolqui. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on December 02, 2002. There are currently 190 (2021) people employed by Prophar S.A.. In 2022, the company reported a net sales revenue increase of 20.97%. During that time, Prophar S.A.’s total assets grew by 2.39%. In, 2022, the company’s net profit margin decreased by 1.48%.

Headquarters
Av. General Ruminahui
Sangolqui; Pichincha;

Contact Details: Purchase the Prophar S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Prophar S.A. report to view the information.
Outstanding Shares:
Purchase the Prophar S.A. report to view the information.
Registered Capital:
Purchase the Prophar S.A. report to view the information.
Incorporation Date:
December 02, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
69.74%
Purchase this report to view the information.
11.93%
Purchase this report to view the information.
6.4%
Purchase this report to view the information.
6.4%
Purchase this report to view the information.
1.38%
Company Performance
Financial values in the chart are available after Prophar S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
20.97%▲
Total operating revenue
32.56%▲
Operating profit (EBIT)
166%▲
EBITDA
71.67%▲
Net Profit (Loss) for the Period
-40.28%▼
Total assets
2.39%▲
Total equity
2.43%▲
Operating Profit Margin (ROS)
12.04%▲
Net Profit Margin
-1.48%▼
Return on Equity (ROE)
-0.91%▼
Debt to Equity Ratio
4.36%▲
Quick Ratio
0.68%▲
Cash Ratio
0.36%▲

Similar companies

Laboratorios Siegfried S.A.
 
Roche Ecuador S.A.
Bayer S.A.
 
Novartis Ecuador S.A.
Laboratorios Industriales Farmaceuticos Ecuatorianos Life
 
Farmayala Pharmaceutical Company S.A.
Laboratorio Farmaceutico Lamosan C.L.
 
Carvagu S.A.
Farbiopharma S.A.
 
Jaspharm CIA Ltda
Distribuidora Comercial la Raiz Discomraiz S.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo